Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus

Ovarian cancer is often termed a silent killer due to the late onset of symptoms. Whilst patients initially respond to chemotherapy, they rapidly develop chemo-resistance. Oncolytic adenoviruses (OAds) are promising anti-cancer agents engineered to “hijack” the unique molecular machinery of cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulin-Curtis, Sarah L., Davies, James A., Jones, Rachel, Hudson, Emma, Hanna, Louise, Chester, John D., Parker, Alan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995174/
https://www.ncbi.nlm.nih.gov/pubmed/29899862
http://dx.doi.org/10.18632/oncotarget.25242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995174/
https://www.ncbi.nlm.nih.gov/pubmed/29899862
http://dx.doi.org/10.18632/oncotarget.25242

Ejemplares similares